Angelina Jolie has ovaries, fallopian tubes removed over cancer concerns
the ONA take:
Actress Angelina Jolie announced Tuesday that she underwent surgery to remove her fallopian tubes and ovaries out of fear of a hereditary form of cancer.
Having lost her mother, grandmother, and aunt to cancer, Jolie underwent a double mastectomy 2 years ago over similar concerns. Jolie opted to have her ovaries and fallopian tubes last weeks after a blood test revealed that she may be in the early stages of cancer.
After Jolie underwent the procedure to remove both of her breasts, the pros and cons of preventative measures were pushed into the spotlight, ultimately causing the "Angelina Jolie effect," in which there was an increase in women with genuine concerns about their family history of breast cancer seeking advice from health care professionals. Her announcement could produce the same effect for women concerned about their risk of ovarian cancer.
Further tests showed that the actress was not actually in the early stages of cancer, but she opted for the surgery before of her family history and because she carries the BRCA1 gene mutation that increases her risk of developing ovarian cancer by 50% and breast cancer by 87%.
Actress Angelina Jolie underwent surgery to remove her fallopian tubes and ovaries out of fear of a hereditary form of cancer.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|